kras mutation and glutathion glynac Treatment of KRAS-Mutated Pancreatic Cancer: New Hope for the Patients? Oncometabolites in pancreatic cancer: Strategies

Oncometabolites in pancreatic cancer: Strategies and its implications PMC Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Supplementing Glycine and N Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial PMC Targeting mutated GTPase KRAS in tumor therapies ScienceDirect The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy PMC Metabolic reprogramming in KRAS mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies ScienceDirect

SKU: 98768295422 · From reganhouse.co.nz